Spruce Biosciences Inc
NASDAQ:SPRB

Watchlist Manager
Spruce Biosciences Inc Logo
Spruce Biosciences Inc
NASDAQ:SPRB
Watchlist
Price: 84 USD 0.31% Market Closed
Market Cap: 89.9m USD

Wall Street
Price Targets

SPRB Price Targets Summary
Spruce Biosciences Inc

Wall Street analysts forecast SPRB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRB is 213.69 USD with a low forecast of 161.6 USD and a high forecast of 271.95 USD.

Lowest
Price Target
161.6 USD
92% Upside
Average
Price Target
213.69 USD
154% Upside
Highest
Price Target
271.95 USD
224% Upside
Spruce Biosciences Inc Competitors:
Price Targets
301080
Acrobiosystems Co Ltd
39% Upside
DVAX
Dynavax Technologies Corp
38% Upside
TGTX
TG Therapeutics Inc
45% Upside
VCEL
Vericel Corp
49% Upside
ACE
Ascelia Pharma AB
157% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
48% Upside
IVVD
Invivyd Inc
166% Upside
4974
Takara Bio Inc
40% Upside

Revenue
Forecast

Revenue Estimate
Spruce Biosciences Inc

The compound annual growth rate of Spruce Biosciences Inc's revenue for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Spruce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Spruce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPRB's stock price target?
Price Target
213.69 USD

According to Wall Street analysts, the average 1-year price target for SPRB is 213.69 USD with a low forecast of 161.6 USD and a high forecast of 271.95 USD.

What is Spruce Biosciences Inc's Revenue forecast?
Projected CAGR
28%

The compound annual growth rate of Spruce Biosciences Inc's revenue for the next 3 years is 28%.

Back to Top